期刊文献+

滑膜肉瘤预后相关因素分析 被引量:2

Evaluation of prognostic factors for synovial sarcoma
原文传递
导出
摘要 目的 分析影响滑膜肉瘤患者预后的相关因素.方法 回顾性分析1997年9月至2008年9月就诊的66例滑膜肉瘤患者中52例获得随访的患者的临床资料.其中男性28例,女性24例;发病年龄11~71岁,均以无痛性肿块入院.通过随访了解肿瘤学预后,明确3、5年总体生存率及局部复发率.通过回顾病例,分析年龄、性别、肿瘤部位、肿瘤直径、外科边界、病理亚型、局部治疗方式、是否侵及骨与神经血管以及是否化疗9项因素对总体生存率的影响.利用Kaplan-Meier生存分析确定对生存有影响的单个因素,并通过Cox回归分析明确影响预后的独立危险因素.结果 52例患者获得随访,随访率78.8%;随访时间6 ~ 88个月,中位随访时间32个月.患者5年总体生存率为30.3%,局部复发率为32.7%,中位复发时间16个月.单因素分析结果提示:肿瘤直径<5 cm、取得广泛外科边界、肿瘤位于四肢以及采取广泛切除联合局部放疗的患者预后较好(P<0.05).多因素分析显示肿瘤直径,部位以及是否取得广泛外科边界是影响预后的独立危险因素.结论 肿瘤直径、部位以及是否取得广泛外科边界是影响预后的独立危险因素. Objective To determine the independent prognostic factors of primary synovial sarcoma.Methods The clinical data of 52 patients followed up from 66 patients with synovial sarcoma treated between September 1997 and September 2008 was analyzed retrospectively.There were 28 male and 24 female patients aged from 11 to 71 years old.Three and five-year overall survival (OS),recurrence rate and 9 prognostic factors were analyzed in this study.Univariate and multivariate analysis were performed to determine the prognostic factors of OS.Results Fifty-two patients were followed up with the follow-up time ranged from 6 to 88 months (median 32 months).The 3-,5-year overall survival rate and local recurrence rate were 52.8%,30.3% and 32.7% respectively.Univariate showed tumor size 〈5 cm,tumor located at extremities,adequate surgical margin and radical resection combined with radiotherapy had better survival rate (P 〈 0.05 ).Multivariate analysis demonstrated that tumor size,primary site and adequate surgical margin were independent prognostic factors for OS.Patients received radical resection combined with radiotherapy have longer median relapse time(25 months) compared with marginal resection combined with radiotherapy( 18 months) and single radical resection ( 12 months).Thirty-five (67%) patients were treated with chemotherapy and seventeen (33%) patients received no chemotherapy for the primary tumor.Treatment with chemotherapy was not associated with an improved OS ( P =0.52 ).Conclusions The independent prognostic factors of synovial sarcoma are tumor size,primary site and adequate surgical margin.Doxorubicin and ifosfamide based chemotherapy was not associated with an improved OS in patients with synovial sarcoma.Radical resection combined with radiotherapy can best control local condition.
出处 《中华外科杂志》 CAS CSCD 北大核心 2011年第11期991-994,共4页 Chinese Journal of Surgery
关键词 肉瘤 软组织 因素分析 统计学 复发 Sacomas, soft tissue Factor analysis, statistical Recurrence
  • 相关文献

参考文献12

  • 1郭卫.中华骨科学骨肿瘤卷.北京:人民卫生出版社,2006:421.
  • 2Trassard M,Le Doussal V,Hacène K,et al.Prognostic factors in localized primary synovial sarcoma:a multicenter study of 128 adult patients.J Clin Onco1,2001,19:525-534.
  • 3Italiano A,Penel N,Robin YM,et al.Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma:a study of the French Sarcoma Group.Ann Oncol,2009,20:425-430.
  • 4Singer S,Baldini EH,Demetri GD,et al.Synovial sarcoma:prognostic significance of tumor size,margin of resection,and mitotic activity for survival.J Clin Oncol,1996,14:1201-1208.
  • 5Pisters PW,Leung DH,Woodruff J,et al.Analysis of prognostic factors in 1041 patients with localized soft tissue sarcomas of the extremities.J Clin Oncol,1996,14:1679-1689.
  • 6el-Naggar AK,Ayala AG,Abdul-Karim FW,et al.Synovial sarcoma.A DNA flow cytometric study.Cancer,1990,65:2295-2300.
  • 7Evans HL.Synovial sarcoma.A study of 23 biphasic and 17probable monophasic examples.Pathol Annu,1980,15:309-331.
  • 8Okcu MF,Munsell M,Treuner J,et al.Synovial sarcoma of childhood and adolescence:a multicenter,multivariate analysis of outcome.J Clin Onco1,2003,21:1602-1611.
  • 9Lewis JJ,Antonescu CR,Leung DH,et al.Synovial sarcoma:a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity.J Clin Oncol,2000,18:2087-2094.
  • 10Suit HD,Mankin H J,Wilett CG,et al.Limited surgery and external irradiation of soft tissue sarcomas//Ryan JR,Baker L.Recent Concepts in Sarcoma Treatment.Dordrecht:Kluwer Academic Publisher,1988:94-143.

同被引文献16

  • 1王兆亮,朱建善,刘强,林鸿翔,陈以明,周晓燕.原发性肾脏滑膜肉瘤临床病理及分子遗传学分析[J].临床与实验病理学杂志,2006,22(6):684-688. 被引量:11
  • 2Chan WC,Foucar K,Morice WG,et al.T-cell large granular lymphocytic leukaemia-WHO classification of tumor of haematopoietic and lymphoid tissues[M].Lyon:IARC Press.2008.272-273.
  • 3Clemente MJ,Wlodarski MW,Makishima H,et al.Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granularlymphocyte leukemia[J].Blood,2011,118 (16):4384-4393.
  • 4Dincol G,Diz-Ku,ukkaya R,et al.T-cell large granular lymohocytic leukaemia:successful response to 2-deoxycoformycin[J].Neth J Med,2008,66 (2):85-87.
  • 5Chan WC,Links S,Mawle A,et al.Heterogeneity of large granular lymphocyte proliferations:delineation of two major subtypes[J].Blood,1986,68 (5):1142-1153.
  • 6Pandolfi F,Loughran TP,Jr,et al.Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes[J].A mulitcenter study.Cancer,1990,65 (2):341-348.
  • 7Lima M,Almeida J,Dos Anjos TM,et al.TCR alphabeta +/CD4 + large granular lymphocytosis:a new clonal T-cell lymphoproliferative disorder[J].Am J Pathol,2003,163 (2):763-771.
  • 8Sandberg Y,Almeida J,Gonzalez M,et al.TCR gammadelta + large granular lymphocyte leukemias reflect the spectrum of normal antigenselected TCR gammadelta + T-cells[J].Leukemia,2006,20 (3):505-513.
  • 9Semenzato G,Zambello R,Starkebaum G,et al.The lymphoproliferative disease of granular lymphocytes:updated criteria for diagososis[J].Blood,1997,89 (1):256-260.
  • 10Lamy T,Loughran TP Jr.Clinical features of large granular lymphocyte leukemia[J].Seminars in Hematology,2003,40(3):185-195.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部